The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Synonyms :
Class :
Brand Name :
Synonyms :
Class :
Administer 10ml orally twice or thrice a day.
Do not exceed 60mg in a day.
<1 year: Safety and efficacy not established
>1 year: Administer 0.5 to 1mg/kg/body weight divided in three doses per day.
May have an increasingly adverse effect when combined with Serotonin/Norepinephrine Reuptake Inhibitors
May have an increasingly adverse effect when combined with Serotonin/Norepinephrine Reuptake Inhibitors
may have an increased adverse effect when combined with antipsychotic agents
may have an increased adverse effect when combined with antipsychotic agents
may have an increased adverse effect when combined with antipsychotic agents
may have an increased adverse effect when combined with antipsychotic agents
may have an increased adverse effect when combined with antipsychotic agents
may have an increased adverse effect when combined with tetrabenazine
may have an increasingly adverse effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with antipsychotic agents
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
may have an increasingly adverse effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with antipsychotic agents
may have an increasingly adverse effect when combined with antipsychotic agents
it increases the toxicity of SSRIs
it increases the toxicity of SSRIs
it increases the toxicity of SSRIs
it increases the toxicity of SSRIs
it increases the toxicity of SSRIs
bromopride: they may enhance the serum concentration of CYP2D6 Inhibitors
bromopride: they may enhance the serum concentration of CYP2D6 Inhibitors
bromopride: they may enhance the serum concentration of CYP2D6 Inhibitors
bromopride: they may enhance the serum concentration of CYP2D6 Inhibitors
bromopride: they may enhance the serum concentration of CYP2D6 Inhibitors
may increase the toxic effect of antipsychotics
metyrosine: they may increase the toxic effect of bromopride
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
The Therapeutic efficacy of quinagolide might be reduced
bromopride: they may increase the CNS depressant effect of CNS Depressants
bromopride: they may increase the CNS depressant effect of CNS Depressants
bromopride: they may increase the CNS depressant effect of CNS Depressants
the side effects of dopamine agonists are increased with bromopride when combined
the side effects of dopamine agonists are increased with bromopride when combined
the side effects of dopamine agonists are increased with bromopride when combined
the side effects of dopamine agonists are increased with bromopride when combined
the side effects of dopamine agonists are increased with bromopride when combined
hydrocodone/​chlorpheniramine/​pseudoephedrineÂ
may increase the CNS depressant activity of CNS depressants
may increase the CNS depressant effect
may increase the CNS depressant effect
may increase the toxic effects of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS Depressants
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
